UK cohort | NHLBI cohort | |||||
Untreated | p-value# | Rapamycin | p-value# | Untreated | p-value# | |
Subjects n | 64 | 27 | 136 | |||
ΔFEV1 mL per year | −32.6±111.2 | ns | 24.3±141.4 | ns | −94.7±96.2 | ns |
ΔDLCO mmol·min−1·kPa−1 per year | −0.2±0.40 | ns | −0.17±0.23 | ns | −0.23±0.31 | ns |
VTDB µg·mL−1 | 273±96 | 281±105 | 255±53.4 |
Data are presented as mean±sd, unless otherwise stated. NHLBI: National Heart, Lung and Blood Institute. #: p-value for Spearman's correlation with serum VTDB. ns: nonsignificant.